About Us
Research Watch

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Researchers

Sonam Puri, Nofisat Ismaila, Ibrahim Hanna Azar, Janet Freeman-Daily, Naoki Furuya, Sara Kuruvilla, Logan Roof, Ana I Velazquez, Yubao Wang, Paul Wheatley Price, Natasha B Leighl

Abstract

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the <i>ASCO Guidelines Methodology Manual</i>. ASCO Living Guidelines follow the <i>ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines</i>. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (<i>Appendix I</i> and <i>Appendix II</i>). Updates are published regularly and can be found on the <i>ASCO Publications website</i>.
Source: PubMed (PMID: 42372216)View Original on PubMed